Walleye Capital
FOMX

Walleye Capital’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Walleye Capital’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$364K Buy
+63,456
New +$363K 0.17% 154

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Walleye Capital's FOMX Position: Q3 2018 in Review

Walleye Capital opened a new position in Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2018: 63,456 shares worth $364K. The stake represents 0.17% of the portfolio and ranks #154 among its holdings.

75 funds tracked by Wall St. Rank hold FOMX as of Q3 2018.

  • Walleye Capital held 63,456 shares of Foamix Pharmaceuticals Ltd. Ordinary Shares worth $364K as of Q3 2018.
  • Foamix Pharmaceuticals Ltd. Ordinary Shares was a new Walleye Capital position in Q3 2018.
  • Foamix Pharmaceuticals Ltd. Ordinary Shares made up 0.17% of Walleye Capital's portfolio in Q3 2018, its #154 holding.
  • 75 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2018.

Based on Walleye Capital's 13F filing for Q3 2018, filed 14 Nov 2018.